Anthropic extols ais drug rd potential including risks mammoth ipo filing

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 26 Oct, 19:19 UTC

Artificial intelligence giant Anthropic is pushing deeper into drug discovery, building its own molecular biology lab and investing in research that could eventually produce drug candidates, according to the company's blockbuster IPO filing.

aibusinessscience

Sources

• T2Anthropic extols ais drug rd potential including risks mammoth ipo filingFierce Biotech / Fierce Healthcare / MedCity / GEN26 Oct, 19:19